1. Home
  2. Labeler Index
  3. Aphena Pharma Solutions - Tennessee, Llc
  4. 71610-765
  5. Product Images: Pregabalin

Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Bottle Label 75 mg - 71610 0765 30
  2. Aphena Pharma Solutions - TN - Aphena
  3. Figure 1 - pregabalincaps fig01
  4. Figure 2 - pregabalincaps fig02
  5. Figure 3 - pregabalincaps fig03
  6. Figure 4 - pregabalincaps fig04
  7. Figure 5 - pregabalincaps fig05
  8. Figure 6 - pregabalincaps fig06
  9. Figure 7 - pregabalincaps fig07
  10. Figure 8 - pregabalincaps fig08
  11. Figure 9 - pregabalincaps fig09
  12. Figure 11 - pregabalincaps fig10
  13. Figure 12 - pregabalincaps fig11
  14. Cockcroft and Gault equation - pregabalincaps formula
  15. Chemical Structure - pregabalincaps str

Product Label Images

The following 15 images provide visual information about the product associated with Pregabalin NDC 71610-765 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Bottle Label 75 mg - 71610 0765 30

Bottle Label 75 mg - 71610 0765 30

Aphena Pharma Solutions - TN - Aphena

Aphena Pharma Solutions - TN - Aphena

Figure 1 - pregabalincaps fig01

Figure 1 - pregabalincaps fig01

Figure 2 - pregabalincaps fig02

Figure 2 - pregabalincaps fig02

Figure 3 - pregabalincaps fig03

Figure 3 - pregabalincaps fig03

Figure 4 - pregabalincaps fig04

Figure 4 - pregabalincaps fig04

Figure 5 - pregabalincaps fig05

Figure 5 - pregabalincaps fig05

Figure 6 - pregabalincaps fig06

Figure 6 - pregabalincaps fig06

Figure 7 - pregabalincaps fig07

Figure 7 - pregabalincaps fig07

Figure 8 - pregabalincaps fig08

Figure 8 - pregabalincaps fig08

Figure 9 - pregabalincaps fig09

Figure 9 - pregabalincaps fig09

This text appears to be a table showing the estimated percentage of subjects without LTR (Long Term Relief) for a certain study. The table includes percentages ranging from 100% to 0%, spaced at intervals of 10%. The table also mentions two groups: "Progabain" and "Placebo". The numbers "20", "40", "80", and "120" are listed horizontally beneath the headings "Days". It is unclear what exactly these numbers signify without additional context.*

Figure 11 - pregabalincaps fig10

Figure 11 - pregabalincaps fig10

Figure 12 - pregabalincaps fig11

Figure 12 - pregabalincaps fig11

This text provides information on the percent of subjects improved over a period of time. The data shows a range of values from 100 to 280, with specific values at 210, 220, 230, 240, 250, 260, and 270. It also mentions the comparison between Pregabalin and Placebo. However, without further context or additional information, it is difficult to interpret the significance of these numbers.*

Cockcroft and Gault equation - pregabalincaps formula

Cockcroft and Gault equation - pregabalincaps formula

This text appears to be an equation for calculating CLCT (Clearance of Creatinine) in patients. It involves variables such as age, weight, and serum creatinine levels. However, the output is not completely clear and contains non-English characters. Therefore, the information is not available.*

Chemical Structure - pregabalincaps str

Chemical Structure - pregabalincaps str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.